• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy programs will be updated July 1, 2021:

Effective August 1, 2021:

  • Acute Migraine Agents
  • Alpha-1 Proteinase Inhibitors
  • Antidepressant Agents
  • Cannabidiol
  • Coagulation Factor X
  • Galafold (migalastat)
  • Hetlioz (Previously Circadian Rhythm Disorder)
  • Jynarque
  • Lysosomal Storage Disorders
  • Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) Inhibitors
  • Peanut Allergy
  • Substrate Reduction Therapy

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant. 
Institutional Providers
Professional Providers